D
Diffusion Pharmaceuticals Inc
F:DP81
Diffusion Pharmaceuticals Inc
F:DP81
Price:
0.1896
EUR
-9.28%
Market Closed
Market Cap:
€386.5k
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
D
|
Diffusion Pharmaceuticals Inc
F:DP81
|
US |
|
G
|
Goodyear Tire & Rubber Co
DUS:GTR
|
US |
|
N
|
NNIT A/S
F:5NN
|
DK |
|
I
|
Intensity Therapeutics Inc
NASDAQ:INTS
|
US |
|
M
|
Malee Group PCL
SET:MALEE
|
TH |
|
Central Retail Corporation PCL
SET:CRC
|
TH |
Wall St Price Targets
DP81 Price Targets Summary
Diffusion Pharmaceuticals Inc
Diffusion Pharmaceuticals Inc
Wall Street analysts forecast DP81 stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for DP81 is 1.1634 EUR with a low forecast of 0.5236 EUR and a high forecast of 1.9441 EUR.
Lowest Forecast
Price Target
0.5236
EUR
176% Upside
Average Forecast
Price Target
1.1634
EUR
514% Upside
Highest Forecast
Price Target
1.9441
EUR
925% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is DP81's stock price target?
Price Target
1.1634
EUR
1.1634
EUR
According to Wall Street analysts, the average 1-year price target for DP81 is 1.1634 EUR with a low forecast of 0.5236 EUR and a high forecast of 1.9441 EUR.
What is the Revenue forecast for Diffusion Pharmaceuticals Inc?
Projected CAGR
95%
95%
Over the last 13 years, the compound annual growth rate for Revenue has been 20%. The projected CAGR for the next 8 years is 95%.
